Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5098014011 | Acute myeloid leukemia with BCR-ABL1 | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 5098015012 | Acute myeloid leukemia with BCR-ABL1 (disorder) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 5098016013 | Acute myeloid leukemia with t(9;22)(q34.1;q11.2) | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5098017016 | Acute myeloid leukaemia with BCR-ABL1 | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 5098018014 | Acute myeloid leukaemia with t(9;22)(q34.1;q11.2) | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5098019018 | A rare acute myeloid leukemia (AML) with recurrent genetic anomaly characterized by the presence of bone marrow and peripheral blood myeloblasts with features ranging from those of minimal differentiation to granulocytic maturation, demonstrating t(9;22)(q34.1;q11.2) or molecular genetic evidence of BCR-ABL1 fusion. Evidence of chronic myeloid leukemia (CML) is absent. Patients most commonly present with leukocytosis with blast predominance and variable anemia and thrombocytopenia. Splenomegaly is less frequent and peripheral blood basophilia lower than in patients with myeloid blast transformation of CML. The disease occurs primarily in adults, and response to traditional AML therapy or tyrosine kinase inhibitor therapy alone is typically poor. | en | Definition | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 5098020012 | A rare acute myeloid leukaemia (AML) with recurrent genetic anomaly characterised by the presence of bone marrow and peripheral blood myeloblasts with features ranging from those of minimal differentiation to granulocytic maturation, demonstrating t(9;22)(q34.1;q11.2) or molecular genetic evidence of BCR-ABL1 fusion. Evidence of chronic myeloid leukaemia (CML) is absent. Patients most commonly present with leucocytosis with blast predominance and variable anaemia and thrombocytopenia. Splenomegaly is less frequent and peripheral blood basophilia lower than in patients with myeloid blast transformation of CML. The disease occurs primarily in adults, and response to traditional AML therapy or tyrosine kinase inhibitor therapy alone is typically poor. | en | Definition | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Acute myeloid leukemia with BCR-ABL1 | Is a | Acute myeloid leukemia due to recurrent genetic abnormality | false | Inferred relationship | Some | ||
| Acute myeloid leukemia with BCR-ABL1 | Finding site | Bone marrow structure | true | Inferred relationship | Some | 1 | |
| Acute myeloid leukemia with BCR-ABL1 | Associated morphology | Acute myeloid leukemia with BCR::ABL1 fusion | true | Inferred relationship | Some | 1 | |
| Acute myeloid leukemia with BCR-ABL1 | Is a | Acute myeloid leukemia, disease | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR